These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 26124386

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D, O'Dorisio TM, Sue O'Dorisio M, Lal G, Sugg S, Weigel RJ, Howe JR.
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [Abstract] [Full Text] [Related]

  • 23. Isthmus-preserving total bilobectomy: an adequate operation for C-cell hyperplasia.
    Wahl RA, Vorländer C, Kriener S, Pedall J, Spitza M, Hansmann ML.
    World J Surg; 2006 May; 30(5):860-71. PubMed ID: 16680601
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities.
    Perry A, Molberg K, Albores-Saavedra J.
    Cancer; 1996 Feb 15; 77(4):750-6. PubMed ID: 8616768
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunohistochemistry of medullary thyroid carcinoma and C-cell hyperplasia by an affinity-purified anti-human calcitonin antiserum.
    Hayashida CY, Alves VA, Kanamura CT, Ezabella MC, Abelin NM, Nicolau W, Bisi H, Toledo SP.
    Cancer; 1993 Aug 15; 72(4):1356-63. PubMed ID: 8339225
    [Abstract] [Full Text] [Related]

  • 32. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
    Niccoli-Sire P, Murat A, Rohmer V, Gibelin H, Chabrier G, Conte-Devolx B, Visset J, Ronceray J, Jaeck D, Henry JF, Proye C, Carnaille B, Kraimps JL, Groupe D'étude Des Tumeurs Endocrines.
    Surgery; 2003 Dec 15; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
    [Abstract] [Full Text] [Related]

  • 33. Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.
    Scheuba C, Kaserer K, Bieglmayer C, Asari R, Riss P, Drosten R, Niederle B.
    Surgery; 2007 Dec 15; 142(6):1003-10; discussion 1010.e1-3. PubMed ID: 18063088
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. C-cell hyperplasia and medullary thyroid carcinoma in the rat. An immunohistochemical and ultrastructural analysis.
    DeLellis RA, Nunnemacher G, Bitman WR, Gagel RF, Tashjian AH, Blount M, Wolfe HJ.
    Lab Invest; 1979 Feb 15; 40(2):140-54. PubMed ID: 431034
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC.
    J Clin Endocrinol Metab; 1994 Jan 15; 78(1):114-20. PubMed ID: 7904611
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.